Altus Spine receives patent clearance for Pars repair device to treat symptomatic adolescent spondylolysis


West Chester, Pennsylvania – Thursday, September 8e2022 /OrthoSpineNews/– Altus Spine, a leader in the development and innovation of medical devices used in spine correction surgery, has received notice of clearance from the United States Patent and Trademark Office for its Pars new repair device. This new device aims to provide a more elegant solution to the treatment of spondylolysis resistant to conservative treatments. The Pars Repair Device is the result of more than five years of continuous development, and the current effort extends and expands the work of four prior patents developed by Dr. Carl Giordano of Atlantic Spine Specialists and Dr. Jeffrey Spivak of the Hospital for Joint Diseases, NYU.

“After many modifications and new innovations to this Pars repair device, myself and the entire team at Altus Spine are thrilled to have received patent clearance on this life-changing device. “Said Michael Fitzgerald, President and CEO of Altus Spine, “This collaboration with Drs. Giordano and Spivak has been an honor, and the resulting device is truly remarkable.

The new patented Pars Repair Device offers an innovative solution for the treatment of symptomatic adolescent spondylolysis that is resistant to conservative care. The adult manifestation of this untreated adolescent condition is symptomatic isthmic spondylolisthesis for which 50,000 fusions are performed annually in the United States. By treating the adolescent condition, the device aims to reduce the likelihood of isthmic spondylolisthesis in adults. The present invention is designed to fill a clinical care void that exists in the treatment of these conditions.

Comprised of a spinous process plate, a laminar plate, a sublaminar hook, and a rod, the device includes first and second fixation members configured to traverse the spinous process plate and the laminar plate, respectively. The stem anchored at the distal end to the third fixation member extends substantially perpendicular to the longitudinal axis of the stem, providing multiplanar fixation components.

“Although many techniques exist to repair spondylolysis, none of the currently available techniques provide the segmental rigid multiplanar fixation that we are used to with other fracture fixation surgeries,” said Dr. Giordano. “I have personally performed thousands of these fusion surgeries over the years for isthmic spondylolisthesis in adults and I believe this new Pars repair device will enter the field, it could dramatically change the treatment paradigm for I believe this technique will become the standard of care for the treatment of spondylolysis in adolescents and adults,” explained Dr. Giordano.

To learn more about the newly patented Pars Repair Device, please contact [email protected]

Altus Thorn
Based in West Chester, PA, Altus Spine is dedicated to creating the next generation of medical devices. Altus strives to improve patient care by designing and manufacturing products that meet the highest standards in an ever-changing field. Implemented and used by more than 100 hospitals across the United States, Altus is one of the fastest growing spinal implant companies in the world. For more information or to inquire about distribution opportunities, please contact us at [email protected]

Forward-looking statements
All statements made in the above press release, except for historical facts, may be forward-looking statements that involve risks, uncertainties and assumptions. These factors could cause Altus Spine’s results to differ from those expected if they do not occur as expected. These uncertain factors include, but are not limited to: acceptance and clearance of the Company’s surgical products and procedures, development of new products and procedures, innovations and changes to existing products and procedures, verification clinical and statistical success in using Altus Spine’s products, the company’s ability to maintain and monitor inventory as it introduces new products, its ability to hire and retain personnel, and any other risks indicated in prior or subsequent press releases. Given the constant evolution of the market, readers are encouraged not to place undue reliance on forward-looking statements. Altus Spine undertakes no obligation to update forward-looking statements as such changes occur, or as events and circumstances change, after the date of their publication.


About Author

Comments are closed.